MARAGANORE JOHN has filed 14 insider transactions across 6 companies since September 2022.
Most recent transaction: a grant/award of 107338 shares of Hemab Therapeutics Holdings, Inc. ($COAG) on January 29, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2026 | Hemab Therapeutics Holdings, Inc. | $COAG | MARAGANORE JOHN | Not found | A | Warrants (Right to Buy) | 107338 | $0.00 | 107,338.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. | $COAG | MARAGANORE JOHN | Not found | C | Series C Preferred Stock | 817 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. | $COAG | MARAGANORE JOHN | Not found | C | Common Stock | 17974 | $0.00 | 35,948.0000 | 0 | 100.00% | 0.00% |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. | $COAG | MARAGANORE JOHN | Not found | C | Common Stock | 17974 | $0.00 | 17,974.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2026 | Hemab Therapeutics Holdings, Inc. | $COAG | MARAGANORE JOHN | Not found | C | Series B Preferred Stock | 817 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 25, 2025 | Kymera Therapeutics, Inc. | $KYMR | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 75,043,991 | 9999.99% | 0.02% |
| June 17, 2025 | Rapport Therapeutics, Inc. | $RAPP | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 21850 | $0.00 | 21,850.0000 | 36,496,437 | 9999.99% | 0.06% |
| June 4, 2025 | Beam Therapeutics Inc. | $BEAM | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 33662 | $0.00 | 33,662.0000 | 82,313,008 | 9999.99% | 0.04% |
| June 18, 2024 | Kymera Therapeutics, Inc. | $KYMR | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 58,365,499 | 9999.99% | 0.03% |
| June 5, 2024 | Beam Therapeutics Inc. | $BEAM | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 23114 | $0.00 | 23,114.0000 | 77,151,771 | 9999.99% | 0.03% |
| June 29, 2023 | PROKIDNEY CORP. | $PROK | MARAGANORE JOHN | Director | A | Director stock option (right to buy) | 48128 | $0.00 | 48,128.0000 | 171,578,320 | 9999.99% | 0.03% |
| June 15, 2023 | Kymera Therapeutics, Inc. | $KYMR | MARAGANORE JOHN | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 53,933,229 | 9999.99% | 0.02% |
| June 6, 2023 | Beam Therapeutics Inc. | $BEAM | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 16532 | $0.00 | 16,532.0000 | 70,015,305 | 9999.99% | 0.02% |
| Sept. 20, 2022 | AGIOS PHARMACEUTICALS, INC. | $AGIO | MARAGANORE JOHN | Director | G | Common stock | 1500 | $0.00 | 28,528.0000 | 70,550,631 | 5.00% | 0.00% |